Повысь уровень инвестиционной грамотности и стань профессионалом с курсами от Societe Financiers!Подробнее
  1. Home
  2. Stock quotes
  3. Cytokinetics, Incorporated
  4. Financial Ratios
Cytokinetics, Incorporated logo
Cytokinetics, Incorporated CYTK
$ 37.36 -7.8%
mail-toReport an Error

Annual report 2024
added 02-27-2025

report update icon

Cytokinetics, Incorporated Financial Ratios 2011-2025 | CYTK

Annual Financial Ratios Cytokinetics, Incorporated

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -0.0 -0.0 -0.0 -0.0 -0.0 -6.1 -3.6 -3.6 24.4 -8.0 -17.3 -6.5 -3.0 -1.5

P/S

 0.3 0.9 0.0 0.0 0.0 27.6 12.0 34.0 3.8 10.4 5.4 7.1 15.8 18.4

EPS

 -5.3 -5.5 -4.3 -2.8 -2.0 -2.1 -1.9 -2.6 0.4 -1.0 -0.4 -1.2 -2.3 -0.7

EV (Enterprise Value)

 1.45 B 1.1 B 1.06 B 488 M 339 M 1 B 521 M 514 M 410 M 280 M 274 M 228 M 112 M 59.4 M

EBITDA per Share

 -4.7 K -5.02 K -3.54 K -2.39 K -1.43 K -1.69 -1.61 -2.26 0.486 -0.949 -0.399 -1.23 -2.2 -3.85

EV/EBITDA

 -2.7 -14.4 -8.5 -4.3 -3.2 18.8 -6.7 -16.3 -5.9 -2.6 -1.2

PEG

 -0.0 -0.0 -0.0 -0.0 -0.0 0.74 -0.14 0.0 0.17 0.06 -0.26 -0.15 -0.06 -0.24

P/B

 -0.0 -0.0 -0.0 0.0 0.0 -67.7 14.6 4.1 4.3 4.4 2.8 4.0 1.7 1.5

P/CF

 -0.0 -0.0 -0.0 -0.0 0.1 -7.9 -3.7 -4.3 11.3 69.2 -5.5 -26.5 -3.6 -1.6

ROE %

 435.49 136.22 360.48 -88.29 -112.27 1112.66 -409.84 -116.34 17.44 -54.67 -15.91 -61.93 -57.60 -99.34

ROA %

 -42.06 -63.84 -38.33 -25.59 -23.85 -41.99 -50.33 -43.35 9.67 -32.54 -11.01 -40.53 -52.06 -90.69

ROCE %

 396.13 128.44 300.47 -76.40 -82.85 -37.48 -47.05 -43.22 13.65 -44.75 -13.52 -60.01 -57.51 -97.08

Current Ratio

 0.9 0.7 0.9 1.4 1.3 9.0 9.4 8.5 4.8 3.6 5.5 3.0 10.8 11.1

DSO

 177.2 34.7 100.3 145.7 31.3 70.1 78.6 30.4 0.1 0.2 362.7 0.1 0.2 1.3

DIO

 - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - -

Operating Cycle

 177.2 34.7 100.3 145.7 31.3 - - - - - - - - -

Cash Conversion Cycle

 177.2 34.7 100.3 145.7 31.3 - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Cytokinetics, Incorporated

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -1.36 -1.31 -1.35 -1.34 -1.38 - -1.52 -0.23 -1.05 - -0.95 -0.86 -0.66 - -0.05 -0.68 -0.66 - -0.5 -0.56 -0.54 - -0.4 -0.51 -0.56 - -0.6 -0.6 -0.62 0.18 0.84 -0.29 -0.31 - -0.23 -0.27 -0.23 - -0.16 -0.23 -0.27 0.22 -0.43 -0.58 -0.53 - -0.45 -0.76 -0.13 - -0.15 -0.23 -0.18

EBITDA per Share

 - - - - -1.29 K - -1.11 K -127 -900 - -842 -764 -563 - 95.8 -529 -505 - -393 -454 -442 - -0.3 -0.41 -0.47 - -0.5 -0.5 -0.55 - 0.86 -0.27 -0.3 - -0.22 -0.27 -0.23 - -0.15 -0.22 -0.26 - -0.42 -0.58 -0.52 - -0.43 -0.64 -0.13 - -0.13 -0.18 -0.15

ROE %

 1090.17 -6.59 1016.16 1877.38 1820.97 795.99 765.44 -155.83 -511.35 -473.29 -476.09 -448.33 -110.99 -73.52 196.87 470.07 799.65 832.51 747.62 392.33 -7.42 -307.79 -344.64 -289.20 -209.55 -116.34 -71.90 -7.08 7.09 17.44 -3.60 -51.86 -54.94 -54.67 -32.05 -25.63 -19.35 -15.91 -13.08 -29.72 -48.25 -61.93 -90.27 -81.48 -66.61 -57.60 -65.91 -73.66 -89.20 -99.34 -22.08 -28.30 -24.31

ROA %

 -54.55 -58.13 -61.95 -57.70 -51.65 -34.12 -43.31 -28.83 -39.74 -28.26 -28.86 -20.26 -16.99 -15.62 -25.82 -35.43 -38.87 -31.42 -41.84 -42.06 -44.02 -37.80 -51.53 -52.08 -48.91 -43.35 -25.41 5.18 8.22 9.67 -2.55 -29.83 -32.16 -32.54 -18.18 -15.00 -12.14 -11.01 -9.51 -20.15 -31.94 -40.53 -63.15 -60.97 -54.42 -52.06 -59.79 -67.00 -81.30 -90.69 -20.16 -25.83 -22.19

ROCE %

 956.74 -1.07 797.58 1448.45 1402.05 602.00 574.22 -132.31 -454.87 -419.97 -415.40 -383.04 -79.25 -50.74 168.03 382.23 655.04 687.22 618.14 330.30 -4.26 -260.11 -285.99 -242.79 -175.45 -69.98 -33.99 27.89 39.15 11.66 -1.30 -50.25 -54.02 -41.39 -47.90 -41.46 -35.15 -25.17 -48.34 -64.99 -83.53 -74.07 -88.44 -79.65 -64.75 -41.33 -63.48 -71.25 -86.79 -74.86 -22.14 -28.33 -24.39

Current Ratio

 1.0 1.1 0.6 0.7 0.8 0.9 1.0 - 1.2 1.4 1.4 1.0 1.1 1.3 1.3 1.3 1.3 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.1 1.6 1.6 1.6 1.6 2.2 2.2 2.2 2.2 2.5 2.5 2.5 2.5 3.2 3.2 3.2 3.2 2.9 2.9 2.9 2.9 10.4 10.4 10.4 10.4 11.5 11.5 11.5 11.5

DSO

 - - 420.5 104.8 11.4 - 41.6 3.1 2300.1 - 28.1 115.8 62.2 - 9.7 112.2 114.3 - 77.8 66.0 39.9 - 19.1 32.8 28.9 -5637.2 16.4 33.2 12.5 0.1 0.0 0.2 1.1 0.9 - - 1.1 0.2 - - 1.2 0.4 - - 10.4 3.9 - - 5.2 12.4 - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - 420.5 104.8 11.4 - 41.6 3.1 2300.1 - 28.1 115.8 62.2 - 9.7 112.2 114.3 - 77.8 66.0 39.9 - 19.1 32.8 28.9 -5637.2 16.4 33.2 12.5 0.1 0.0 0.2 1.1 0.9 - - 1.1 0.2 - - 1.2 0.4 - - 10.4 3.9 - - 5.2 12.4 - - -

Cash Conversion Cycle

 - - 420.5 104.8 11.4 - 41.6 3.1 2300.1 - 28.1 115.8 62.2 - 9.7 112.2 114.3 - 77.8 66.0 39.9 - 19.1 32.8 28.9 -5637.2 16.4 33.2 12.5 0.1 0.0 0.2 1.1 0.9 - - 1.1 0.2 - - 1.2 0.4 - - 10.4 3.9 - - 5.2 12.4 - - -

All numbers in USD currency